Gene · 54541
Papers3,069
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 3,069
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Noncoding RNA therapeutics - challenges and potential solutions. | Nat Rev Drug Discov | 2021 | 34145432 | PubTator, text mining | PubMed |
| Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. | Adv Drug Deliv Rev | 2021 | 34139255 | PubTator, text mining | PubMed |
| Effects of sleep deprivation on sarcopenia and obesity: A narrative review of randomized controlled and crossover trials. | J Frailty Sarcopenia Falls | 2021 | 34131601 | PubTator, text mining | PubMed |
| Potential prognostic markers and significant lncRNA-mRNA co-expression pairs in laryngeal squamous cell carcinoma. | Open Life Sci | 2021 | 34131588 | PubTator, text mining | PubMed |
| RTP801/REDD1 contributes to neuroinflammation severity and memory impairments in Alzheimer's disease. | Cell Death Dis | 2021 | 34131105 | PubTator, text mining | PubMed |
| LncRNA CTD-2528L19.6 prevents the progression of IPF by alleviating fibroblast activation. | Cell Death Dis | 2021 | 34112765 | PubTator, text mining | PubMed |
| Applications of single-cell sequencing in cancer research: progress and perspectives. | J Hematol Oncol | 2021 | 34108022 | PubTator, text mining | PubMed |
| Overexpression of DDIT4 and TPTEP1 are associated with metastasis and advanced stages in colorectal cancer patients: a study utilizing bioinformatics prediction and experimental validation. | Cancer Cell Int | 2021 | 34107956 | PubTator, text mining | PubMed |
| FLI1 mediates the selective expression of hypoxia-inducible factor 1 target genes in endothelial cells under hypoxic conditions. | FEBS Open Bio | 2021 | 34102031 | PubTator, text mining | PubMed |
| The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers. | NPJ Breast Cancer | 2021 | 34099718 | PubTator, text mining | PubMed |
| Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma. | Comput Struct Biotechnol J | 2021 | 34093992 | PubTator, text mining | PubMed |
| Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer. | J Cancer | 2021 | 34093804 | PubTator, text mining | PubMed |
| An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment. | Front Immunol | 2021 | 34093582 | PubTator, text mining | PubMed |
| Microarray analysis reveals ONC201 mediated differential mechanisms of CHOP gene regulation in metastatic and nonmetastatic colorectal cancer cells. | Sci Rep | 2021 | 34088951 | PubTator, text mining | PubMed |
| Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer. | Cancer Biol Med | 2021 | 34086429 | PubTator, text mining | PubMed |
| Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression. | Front Immunol | 2021 | 34084160 | PubTator, text mining | PubMed |
| STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer. | Nat Commun | 2021 | 34083537 | PubTator, text mining | PubMed |
| IR-Surviving NSCLC Cells Exhibit Different Patterns of Molecular and Cellular Reactions Relating to the Multifraction Irradiation Regimen and p53-Family Proteins Expression. | Cancers (Basel) | 2021 | 34071477 | PubTator, text mining | PubMed |
| ATM: Main Features, Signaling Pathways, and Its Diverse Roles in DNA Damage Response, Tumor Suppression, and Cancer Development. | Genes (Basel) | 2021 | 34070860 | PubTator, text mining | PubMed |
| Distinct Concentration-Dependent Molecular Pathways Regulate Bone Cell Responses to Cobalt and Chromium Exposure from Joint Replacement Prostheses. | Int J Mol Sci | 2021 | 34069294 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54541/papers?page=60